Allergan gets label extension OK for dermal fillers
June 26 (Reuters) - Allergan Inc. (AGN.N), which makes the Botox wrinkle treatment, said the U.S. Food and Drug Administration had approved label extensions for its Juvederm dermal fillers.
The company said the approval was based on new clinical data demonstrating that the effects of the products may last for up to one year, which it said was longer than that of other hyaluronic acid dermal fillers.
(Reporting by Saumyadeb Chakrabarty in Bangalore)
((Editing by Anil Kumar; Reuters Messaging: saumya.chakrabarty.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: ALLERGAN DRUG/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS4718
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters